The Lancet in conversation with

By The Lancet GroupMedicine Health & Fitness

The Lancet in conversation with episodes

April 12, 2019 Postoperative pain management and opioids
Inappropriate use of opioids after surgery has contributed substantially to the global opioid epidemic. Lead author Paul Myles (Alfred Hospital and Monash University, Melbourne, Australia) discusses a new Lancet Series that proposes alternative approaches for pain management after surgery.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
12 min
April 07, 2019 A framework convention for alcohol control?
TH Lam (University of Hong Kong) discusses a proposal for an international framework convention for alcohol control, given the totality of recent evidence that there is no safe limit for alcohol consumption.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
12 min
March 29, 2019 c-Section in LMICs
Shakila Thangaratinam (Queen Mary University of London, UK) discusses a systematic review and meta-analysis which highlights the increased risk of perinatal trauma and mortality associated with C-section use in low income and middle income countries.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
18 min
March 20, 2019 Building a tuberculosis-free world
A new Lancet Commission maps out priorities in diagnosis, treatment, prevention, and advocacy efforts to end tuberculosis by 2030. Detailed discussion with two of the commissioners: UN Tuberculosis Special Envoy Eric Goosby, and Paula Fujiwara from the International Union against tuberculosis and lung disease. The podcast is introduced by Liz Zuccala from The Lancet.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
29 min
March 15, 2019 Communicating with children about life-threatening disease
Alan Stein, Brenda Kelly (University of Oxford, UK), and Ruth Bland (Royal Hospital for Children, Glasgow, UK) discuss a two-part Series that is helping to develop guidelines for health-care professionals and families concerning life-threatening conditions in children or their parents.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
26 min
March 08, 2019 Heart failure Series
Patrick Rossignol (University of Lorraine, Nancy University Hospital/INSERM, France) discusses recent progress and future challenges concerning heart failure, notably a widespread lack of implementation of established clinical guidelines.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
17 min
March 01, 2019 Inter-pregnancy interval after stillbirth
Annette Regan (A&M University, Houston, USA) discusses an observational study which assesses an appropriate time interval for conception after stillbirth.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
15 min
February 18, 2019 A once-monthly treatment for opioid use disorder
Mark Greenwald discusses buprenorphine extended release—a once-monthly injected formulation for the treatment of opioid use disorder recently approved by the US FDA.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
13 min
February 08, 2019 Advancing women in science, medicine, and global health
Discussion of a special themed issue introduced by Lancet Editors Jocalyn Clark and Liz Zuccala, with contributions from #LancetWomen advisory group members Ravi Verma (International Center for Research on Women, New Delhi, India), and Imogen Coe (Ryerson University, Toronto, Canada).
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
28 min
January 28, 2019 Global action to confront the pandemics of obesity, undernutrition, and climate change
Discussion with Obesity commission co-authors Bill Dietz (George Washington University, USA) and Boyd Swinburn (University of Auckland, New Zealand), plus three personal testimonies about the impact of obesity relating to stigma, indigenous culture, and health.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
52 min

About The Lancet in conversation with

From the publisher's feed

Niall Boyce, Chloe Wilson, and Callum Davidson—editors at The Lancet— in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and…